FDA.reportPublic FDA data

Application 018647

Type
NDA
Sponsor
KING PHARMS LLC

Application Products#

Product, Drug, Ingredient table
ProductDrugIngredientFormStrengthReference drugReference standard
001CORZIDEBENDROFLUMETHIAZIDE; NADOLOLTABLET;ORAL5MG;40MGYesNo
002CORZIDEBENDROFLUMETHIAZIDE; NADOLOLTABLET;ORAL5MG;80MGYesYes

NDC Listings For This Application#

NDC, Name, Nonproprietary name table
NDCNameNonproprietary nameLabelerMarketing categoryStatus
60793-283CORZIDEnadolol and bendroflumethiazidePfizer Laboratories Div Pfizer IncNDACurrent
60793-284CORZIDEnadolol and bendroflumethiazidePfizer Laboratories Div Pfizer IncNDACurrent

Documents#

Document, Submission type, Date table
DocumentSubmission typeDate
67619SUPPL2021-05-28
67614SUPPL2021-05-27
990SUPPL2013-07-16
33538SUPPL2013-07-15
20141ORIG2011-11-08
33537SUPPL2011-06-27
989SUPPL2011-06-09
15068SUPPL2008-08-07
15067SUPPL2003-06-08